13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D Filed 2026-08-14 Event 2026-08-11 SEC 0001171520-26-000229 →

Bleichroeder LP MDxHealth SA MDXH

Stake: 33.20% Shares: 31,648,563 CUSIP: 58286E102 Class: Ordinary Shares

Item 4 — Purpose of Transaction

Bleichroeder originally acquired beneficial ownership of Shares of the Issuer for investment purposes. On August 11, 2026, certain funds and entities managed by Bleichroeder (the "Funds") entered into securities purchase agreements with the Issuer (the "Securities Purchase Agreements") pursuant to which they purchased in the aggregate 24,229,074 Ordinary Shares (the "Purchased Shares") in a registered direct offering for a per-share purchase price of $0.454. On August 11, 2026, the Funds entered into a lock-up agreement (the "Lock-Up Agreement") with the Issuer pursuant to which, among other things, the Funds agreed not to sell, offer, pledge or otherwise dispose or transfer, or enter into any other agreement (including hedging transactions) that transfers the economic consequences of owning the Purchased Shares, subject to customary exceptions, for a period of 90 days from the date of the Security Purchase Agreements. The Reporting Persons intend to evaluate on an ongoing basis the investment in the Issuer and the options with respect to such investment. In connection with such evaluation, Bleichroeder may seek calls and meetings with members of the Board and/or senior management of the Issuer, or communicate publicly or privately with other stockholders, knowledgeable industry or market observers or other third parties to indicate Bleichroeder's views on issues relating to the strategic direction undertaken by the Issuer and other matters of interest to stockholders generally. Depending on various factors, including the Issuer's financial position, prospects and strategic direction, the outcome of the matters referenced above, other developments concerning the Issuer, actions taken by the Issuer's board of directors, price levels of the Shares, other investment opportunities available to the Reporting Persons, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investments in the Issuer as they deem appropriate, including, without limitation, making or causing further acquisitions of securities of the Issuer, including Shares, from time to time, and disposing of, or cause to be disposed, any or all of the securities of the Issuer, including Shares, beneficially owned by the Reporting Persons at any time The foregoing descriptions of the Securities Purchase Agreements and the Lock-Up Agreement are not complete and are qualified in their entirety by reference to the form of Securities Purchase Agreement included as Exhibit 99.1 to this Schedule 13D and the Lock-Up Agreement included as Exhibit 99.2 to this Schedule 13D, respectively, which are incorporated herein by reference.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
12 filings by this filer
11 other filings in the data moat
Short Interest · settle 2026-07-31
DTC 5.03
1,064,100 shares short · +11.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $232K
Point72 Asset Mgmt

Other 13D/G Filings on MDxHealth SA

FiledFormFilerStakeShares
2023-02-28 SC MVM Partners, LLC view →

Other Filings by Bleichroeder LP

FiledFormIssuerStakeShares
2026-07-09 SCHEDULE 13D/A First Eagle Real Estate Debt Fund 41.00% 1,249,141.59 view →
2026-06-25 SCHEDULE 13D/A Identiv, Inc. (INVE) INVE 19.90% 5,247,467 view →
2026-06-09 SCHEDULE 13D/A LiqTech International, Inc. LIQT 20.90% 6,882,239 view →
2026-05-27 SCHEDULE 13D/A LiqTech International, Inc. LIQT 33.70% 3,182,239 view →
2022-07-05 SC First Eagle Credit Opportunities Fund view →
2022-02-14 SC First Eagle Credit Opportunities Fund view →
2021-10-07 SC First Eagle Credit Opportunities Fund view →
2021-08-17 SC First Eagle Credit Opportunities Fund view →
2021-07-16 SC First Eagle Credit Opportunities Fund view →
2021-06-24 SC First Eagle Credit Opportunities Fund view →
2021-05-19 SC First Eagle Credit Opportunities Fund view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →